share_log

Gemphire Therapeutics | CB/A: Certain tender offers, business combinations and rights offerings, in which the subject company is a foreign private issuer of which less than 10% of its securities are held by U.S. persons (Amendment)

Gemphire Therapeutics | CB/A:合并或股权增发(修正)

美股SEC公告 ·  2007/01/08 23:41
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息